Cencora Inc (NYSE: COR) kicked off on Tuesday, down -0.24% from the previous trading day, before settling in for the closing price of $278.09. Over the past 52 weeks, COR has traded in a range of $214.77-$280.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 10.39% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 12.05%. With a float of $182.78 million, this company’s outstanding shares have now reached $193.85 million.
In an organization with 46000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 3.1%, operating margin of 0.8%, and the pretax margin is 0.61%.
Cencora Inc (COR) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Distribution Industry. The insider ownership of Cencora Inc is 5.74%, while institutional ownership is 91.40%. The most recent insider transaction that took place on Mar 25 ’25, was worth 3,928,917. In this transaction Executive Chairman of this company sold 14,578 shares at a rate of $269.51, taking the stock ownership to the 317,913 shares. Before that another transaction happened on Mar 24 ’25, when Company’s Executive Vice President sold 4,127 for $268.28, making the entire transaction worth $1,107,192. This insider now owns 14,665 shares in total.
Cencora Inc (COR) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.82 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.52% during the next five years compared to 13.29% growth over the previous five years of trading.
Cencora Inc (NYSE: COR) Trading Performance Indicators
Take a look at Cencora Inc’s (COR) current performance indicators. Last quarter, stock had a quick ratio of 0.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.03, a number that is poised to hit 4.05 in the next quarter and is forecasted to reach 16.91 in one year’s time.
Technical Analysis of Cencora Inc (COR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.29 million. That was inferior than the volume of 1.59 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 87.69%. Additionally, its Average True Range was 4.72.
During the past 100 days, Cencora Inc’s (COR) raw stochastic average was set at 94.21%, which indicates a significant increase from 88.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 6.11% in the past 14 days, which was lower than the 18.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $255.22, while its 200-day Moving Average is $239.18. However, in the short run, Cencora Inc’s stock first resistance to watch stands at $279.69. Second resistance stands at $281.97. The third major resistance level sits at $283.94. If the price goes on to break the first support level at $275.44, it is likely to go to the next support level at $273.47. The third support level lies at $271.19 if the price breaches the second support level.
Cencora Inc (NYSE: COR) Key Stats
The company with the Market Capitalisation of 53.79 billion has total of 193,917K Shares Outstanding. Its annual sales at the moment are 293,959 M in contrast with the sum of 1,509 M annual income. Company’s last quarter sales were recorded 81,487 M and last quarter income was 488,600 K.
